Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Utah Medical Products (UTMD) Profit After Tax (2016 - 2025)

Historic Profit After Tax for Utah Medical Products (UTMD) over the last 16 years, with Q3 2025 value amounting to $2.6 million.

  • Utah Medical Products' Profit After Tax fell 2615.77% to $2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.6 million, marking a year-over-year decrease of 2383.51%. This contributed to the annual value of $13.9 million for FY2024, which is 1659.75% down from last year.
  • Per Utah Medical Products' latest filing, its Profit After Tax stood at $2.6 million for Q3 2025, which was down 2615.77% from $3.0 million recorded in Q2 2025.
  • Utah Medical Products' 5-year Profit After Tax high stood at $4.6 million for Q4 2022, and its period low was $2.6 million during Q3 2025.
  • Moreover, its 5-year median value for Profit After Tax was $3.9 million (2023), whereas its average is $3.7 million.
  • Its Profit After Tax has fluctuated over the past 5 years, first soared by 16092.92% in 2021, then crashed by 3230.7% in 2024.
  • Quarter analysis of 5 years shows Utah Medical Products' Profit After Tax stood at $4.1 million in 2021, then grew by 10.26% to $4.6 million in 2022, then decreased by 5.88% to $4.3 million in 2023, then plummeted by 32.31% to $2.9 million in 2024, then decreased by 9.34% to $2.6 million in 2025.
  • Its Profit After Tax stands at $2.6 million for Q3 2025, versus $3.0 million for Q2 2025 and $3.0 million for Q1 2025.